Trudeau Institute, Saranac Lake, NY 12983, USA.
J Immunol. 2013 Jan 1;190(1):296-306. doi: 10.4049/jimmunol.1200571. Epub 2012 Nov 28.
We have previously shown that mice challenged with a lethal dose of A/Puerto Rico/8/34-OVA(I) are protected by injection of 4-8 × 10(6) in vitro-generated Tc1 or Tc17 CD8(+) effectors. Viral load, lung damage, and loss of lung function are all reduced after transfer. Weight loss is reduced and survival increased. We sought in this study to define the mechanism of this protection. CD8(+) effectors exhibit multiple effector activities, perforin-, Fas ligand-, and TRAIL-mediated cytotoxicity, and secretion of multiple cytokines (IL-2, IL-4, IL-5, IL-9, IL-10, IL-17, IL-21, IL-22, IFN-γ, and TNF) and chemokines (CCL3, CCL4, CCL5, CXCL9, and CXCL10). Transfer of CD8(+) effectors into recipients, before infection, elicits enhanced recruitment of host neutrophils, NK cells, macrophages, and B cells. All of these events have the potential to protect against viral infections. Removal of any one, however, of these potential mechanisms was without effect on protection. Even the simultaneous removal of host T cells, host B cells, and host neutrophils combined with the elimination of perforin-mediated lytic mechanisms in the donor cells failed to reduce their ability to protect. We conclude that CD8(+) effector T cells can protect against the lethal effects of viral infection by means of a large number of redundant mechanisms.
我们之前的研究表明,用致死剂量的 A/Puerto Rico/8/34-OVA(I) 感染小鼠后,通过注射 4-8×10(6)个体外生成的 Tc1 或 Tc17 CD8(+)效应细胞,可对其起到保护作用。转移后,病毒载量、肺部损伤和肺功能丧失都有所减少。体重减轻减少,存活率提高。在本研究中,我们试图确定这种保护作用的机制。CD8(+)效应细胞具有多种效应功能,包括穿孔素、Fas 配体和 TRAIL 介导的细胞毒性,以及多种细胞因子(IL-2、IL-4、IL-5、IL-9、IL-10、IL-17、IL-21、IL-22、IFN-γ 和 TNF)和趋化因子(CCL3、CCL4、CCL5、CXCL9 和 CXCL10)的分泌。在感染前将 CD8(+)效应细胞转移到受体中,会引发宿主中性粒细胞、NK 细胞、巨噬细胞和 B 细胞的募集增强。所有这些事件都有可能对病毒感染起到保护作用。然而,去除这些潜在机制中的任何一个,都不会对保护作用产生影响。即使同时去除宿主 T 细胞、宿主 B 细胞和宿主中性粒细胞,并消除供体细胞中的穿孔素介导的溶解机制,也未能降低它们的保护能力。我们得出结论,CD8(+)效应 T 细胞可以通过大量冗余机制来保护免受病毒感染的致命影响。